key: cord-0909177-0mdlcmqs
authors: Yaniv, Karin; Ozer, Eden; Lewis, Yair; Kushmaro, Ariel
title: RT-qPCR assays for SARS-CoV-2 variants of concern in wastewater reveals compromised vaccination-induced immunity
date: 2021-10-28
journal: Water Res
DOI: 10.1016/j.watres.2021.117808
sha: 276ee885bf3737773b2faa4816dde9be8d26d37e
doc_id: 909177
cord_uid: 0mdlcmqs

SARS-CoV-2 variants of concern, demonstrating higher infection rate and lower vaccine effectiveness as compared with the original virus, are important factors propelling the ongoing COVID-19 global outbreak. Therefore, prompt identification of these variants in the environment is essential for pandemic assessment and containment efforts. One well established tool for such viral monitoring is the use of wastewater systems. Here, we describe continuous monitoring of traces of SARS-CoV-2 viruses in the municipal wastewater of a large city in Israel. By observing morbidity fluctuations (during three main COVID-19 surges) occurring in parallel with Pfizer-BioNTech COVID-19 vaccine vaccination rate, compromised immunity was revealed in the current morbidity peak. RT-qPCR assays for the Original (D614G), Alpha and Beta variants had been previously developed and are being employed for wastewater surveillance. In the present study we developed a sensitive RT-qPCR assay designed for the rapid, direct detection of Gamma and Delta variants of concern. Sensitive quantification and detection of the various variants showed the prevalence of the original variant during the first morbidity peak. The dominance of the Alpha variant over the original variant correlated with the second morbidity peak. These variants decreased concurrently with an increase in vaccinations (Feb-March 2021) and the observed decrease in morbidity. The appearance and subsequent rise of the Delta variant became evident and corresponded to the third morbidity peak (June-August 2021). These results suggest a high vaccine neutralization efficiency towards the Alpha variant compared to its neutralization efficiency towards the Delta variant. Moreover, the third vaccination dose (booster) seems to regain neutralization efficiency towards the Delta variant. The developed assays and wastewater-based epidemiology are important tools aiding in morbidity surveillance and disclosing vaccination efforts and immunity dynamics in the community.

Since declaring COVID-19 a world pandemic in March 2020, the disease continues to evolve and affect significant portions of the world population. Increasing circulation of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus within the world population, results in a continual natural processes of random mutations and evolution . In some cases, a mutation will provide the virus an evolutionary advantage and create a new viral lineage that will overpower previous forms. First evidence for such an evolutionary event for the SARS-CoV-2 virus occurred in April 2020, when the D614G substitution enhanced infectivity and transmission. The D614G mutation lineage became the dominant SARS-CoV-2 variant form (Hou et al., 2021; Korber et al., 2020) . By late 2020, the term 'variants of concern' emerged with regards to the high-numbered mutations in a single variant and its increased pathogenicity .

Variants of concern are mainly characterized through mutations in their spike protein gene (S gene). Such mutations affect the receptor biding domain affinity and antibody neutralization efficiency (Weisblum et al., 2020) . Antibody neutralization efficiency is lower when antibodies generated by vaccination or by prior infection are less compatible to the new variants.

Previous studies found that the Alpha variant (B.1.1.7), associated with receptor binding motif replacements, does not significantly reduce the neutralizing antibodies capability, despite its increased infectivity compared to the original strain (Meng et al., 2021) . Mutations in the Beta (B.1.351), Gamma (P.1) and Delta (B.1.617) variants proved to be less susceptible to antibody neutralization (Mlcochova et 4 al., 2021; Planas et al., 2021; Wibmer et al., 2021) . High transmission rates and lower vaccine efficacy towards these variants (Bernal et al., 2021; Hoffmann et al., 2021; Z. Wang et al., 2021) resulted in a greater threat of infectivity and morbidity compared to the original SARS-CoV-2 virus. Therefore, quick detection and quantification of variants of concern, are vital for initiating response and for proper policymaking for pandemic containment.

Currently, SARS-CoV-2 variant detection mainly relies on costly next generation sequencing, where results are obtained within 3-5 days at best (Andrés et al., 2020; Khan et al., 2020) . With new variants of interest constantly emerging, sequencing-based approaches are important for their initial identification, however they present difficulties considering the need for special instruments and resources, including data analysis skills. Thus, to ease detection, a reverse transcriptase quantitative polymerase chain reaction (RT-qPCR)-based assay can provide rapid results for detection of known variants of concern. Such an assay can help assess a variant's frequency within a population and contribute to policy guidelines. Indeed a number of publications targeting variants of concern detection using RT-qPCR (Barreto et al., 2020; Bivins et al., 2021; Gand et al., 2021; Vega-Magaña et al., 2021; Vogels et al., 2021; H. Wang et al., 2021; Yaniv et al., 2021) as well as available commercial kits (e.g., TaqPath ThermoScientific, GT molecular, PerkinElmer) have emerged for individual assessments.

Population morbidity monitoring through wastewater or wastewater-based epidemiology is well described and is considered an important method (Martin et al., 2020) . Its advantage is that it can provide critical information regarding the spread of pathogens in the population in a given area, without relying on individual testing tendencies or testing capacity. Since the beginning of the pandemic, the SARS-CoV-2 virus has been monitored in wastewater around the world Bar-Or et al., 2020; Claro et al., 2021; La Rosa et al., 2020; Sherchan et al., 2020; Trottier et al., 2020; Westhaus et al., 2021; Wu et al., 2021 . Despite this in order to detect specific SARS-CoV-2 variants such as 5 the Gamma and Delta variants of concern, there is a need for a direct and sensitive probe-based RT-qPCR assay with detection ability in wastewater samples. Such a quick and accurate method could thus help generate better health policies in a given region. In this study, we monitored SARS-CoV-2 traces the wastewater of Beer-Sheva, Israel's 4 th largest city (with population of approximately 220,000). Beer-Sheva city is considered a high vaccination area with fluctuating morbidity and was therefore chosen as a model. We deployed a novel sensitive RT-qPCR assay design for the direct detection of Gamma and

Delta variants of concern. The new assay was later employed for wastewater-based epidemiology, together with the RT-qPCR assays developed previously by our group for quantification of the various variants of SARS-CoV-2. These results were then compared to morbidity levels in the population, allowing us to speculate the immunity level in the city population.

The original sequence of SARS-CoV-2 (NC_045512.2) was taken from NCBI database. Gamma variant (P.1, Brazilian, EPI_ISL_981709) and Delta variant (B.1.617, Indian, EPI_ISL_1704637) sequences were taken from GISAID database (Shu and McCauley, 2017) . All primers and probe used in this study are listed in Table S1 . For the Gamma variant, the newly probe design focused on the end of ORF8 and the beginning of N gene 28192-28244bp location that includes it's specific insertion, or S gene 21964-22017 bp location that includes the Delta variant deletion 157-158. All primers and probes were purchased through Integrated DNA Technologies (IDT). ZEN Quencher was added to the probes as a second, internal quencher in qPCR 5'-nuclease assay. Probes were assigned a 6-carboxy-fluorescein (FAM) fluorophore.

Wastewater samples were collected in the cities of Modi'in and Beer Sheva, Israel for 24 hours composite sewage samples. In Modi'in, samples were taken from different manholes (located at the different neighborhoods) and immediately transferred to the lab under chilled conditions. The automated composite samplers (KANDO, Israel) were activated during June 23, 2021. Sampling was carried out for 18 h from 5 AM to 11 PM at each point and collected the next morning. The automated sampler pumped 0.3 L every half an hour (total of 10 L approximately). In Beer-Sheva composite samples were collected by the WWTP facility twice (or three) a week and transferred under chilled conditions as well.

The WWSP'S automated composite sampler was activated for 24 h and pumped 0.25 L of untreated wastewater every half an hour. A temperature of 4 °C maintained during sample transport to the laboratory.

Direct RNA was extracted twice for each sample for duplicates. The RNA extraction procedure was executed according to Zymo Environmental Water RNA (Zymo Research R2042) manufacture protocol including their Viral Enrichment protocol for 5 mL sample volume. For internal control, we added 10 4 or 10 5 copies MS2 phage to the lysis buffer in each RNA extraction. RNA was eluted with 50 μL of RNase free water. The fresh wastewater samples were kept at 4 o C until processed. RNA samples were kept at -80 o C. In the case of Not Detected result after RT-qPCR, the wastewater sample was concentrated using MCE electronegative membrane as described before (Bar-Or et al., 2021) with minor change. 45 ml of wastewater was centrifuged at 3000g for 5 min and the supernatant was collected into separate 50 ml tube containing 1 g of MgCl 2 . The mixture was gently shaken for 5 min and was then split into a duplicate, 20 mL each. Every 20 mL were vacuum pumped through 0.45 μm 47 mm diameter electronegative MCE membrane (Merck Millipore Ltd). The membrane was immediately transferred into a petri dish containing 2 ml lysis buffer of the NucleoSpin RNA extraction kit (Macherey Nagel, Germany) and was gently shaken for 45 min. Following this step, RNA was extracted using the manufacture protocol. Sample processing (raw or concentrated) are color coded in Table S4 . Calculation for RNA copy number per Liter of wastewater was performed equation 1 for raw sample or equation 2 for concentrated samples. 

RT-qPCR was executed as previously described (Yaniv et al., 2021) . Reaction final volume is 20 µL with primers concentration of 0.5 µM and probe concentration of 0.2 µM. The reaction contained 5 µL of RNA sample and ROX as a reference dye. Reaction steps were executed according to manufacture recommended protocol (One Step PrimeScript III RT-qPCR mix RR600 TAKARA, Japan) using Applied Biosystems Thermocycler (Thermo Scientific). For reverse transcription reaction, the reaction holding stage carried out for 7 min at 52℃ followed by 10 sec at 95℃. For PCR reaction, 45 cycles were performed at 95℃ for 5 sec followed by 30 sec at 60℃. Each RT-qPCR run included relevant quality controls, Non template control (NTC) and MS2 phage detection for wastewater RNA sample (Dreier et al., 2005) . MS2 addition was meant for inhibitors assessment through calculated recovery percentage (appear in Table S4 , values were calculated using Fig. S1 ). Ct value initially converted to 8 RNA copies per μL (in the RNA sample) based on the standard curves (as described in the next section).

Duplicate were averaged for each target gene separately. The gene copies per L of wastewater sample were calculated according to equations 1 and 2 for Raw or Concentrated sample respectively.

Calibration curves were performed on a known-positive double-strands DNA template. Three different templates were used and full sequences are reported in Table S3 . (1) Calibration of P.1 probe was performed using the second gene block, while calibration of S∆157 probe was performed with the third gene block. Negative control for the P.1 probe was performed using Wastewater samples confirmed as positive for the original variant or Alpha variant of concern, and negative control for the S∆157 probe was performed using the first gene block. Serial dilutions for the relevant gene block were prepared based on copy number calculations at an initial concentration of 10 6 copies per µL down to 10 0 copies per µL. The resulting Ct values were plotted against the log copy number of the gene block template. Each concentration was examined by six repetitions and a standard deviation was calculated. The lowest concentration tested (i.e., 10 0 copies per µL) was verified for at least 10 times to ensure more than 95% success in positive detection. Linear regression was performed between the log copy number and the Ct values from the RT-qPCR results. In addition, the coefficient of variants between replicates was <3.35% for Gamma assay and <2.94% for the Delta assay. 

Wastewater matrix consist of various PCR inhibitors that are likely to affect the assay performance, therefore there was a need to assess the primers-probe detection abilities in an environment as complex as that. In order to validate the RT-qPCR designed assay's sensitivity in a wastewater matrix, RNA extracted from pre-determined negative wastewater sample for SARS-CoV-2 was examined using standard CDC's detection sets (Centers for Disease Control and Prevention, n.d.).

The negative RNA sample was supplemented with known concentrations of a desired gene block to reach 10 0 ,10 1 and 10 2 copies per µL. All experiments were executed with a pre-determined negative matrix for additional verification of the sample as negative. Eight repetitions were performed for each viral concentration or control. Ct results were plotted to represent the new probes limit of detection in a complex environment.

Throughout the COVID-19 outbreak, we monitored wastewater samples from Beer-Sheva city and several other locations in Israel, for the presence of SARS-CoV-2 virus using RT-qPCR.

Considering that the different SARS-CoV-2 variants share very high similarity in their N gene, we employed N gene detection in prospect of general detection of all the SARS-CoV-2 RNA traces in the wastewater. Using a CDC's standard detection set (CDC's N2) and our previously published designed primer set (Yaniv et al., 2021 ) (Improved N3), we documented the SARS-CoV-2 RNA levels in wastewater and monitored these values together with the corresponding reported active cases and percent vaccination in the city populations (Fig. 1 ). Looking at Figure 1 , it is evident that an increase in detected SARS-CoV2 RNA levels in the city wastewater appeared just prior to every one of the three peaks in reported active cases. Thus, the appearance in the city's wastewater foresaw the increase in reported clinical cases of COVID-19. This result was unsurprising as it is supported by other studies showing that the use of wastewater-based epidemiology is an effective tool for population morbidity monitoring Bar-Or et al., 2020; La Rosa et al., 2020; Trottier et al., 2020; Westhaus et al., 2021; . We then wanted to ascertain if the effects of massive vaccinations could also be assessed using wastewater-epidemiology. In December 2020, Israel began vaccinating its population with the Pfizer-BioNTech BNT162b2 COVID-19 vaccine, with a two dose, three-week interval regimen. Individuals were considered fully vaccinated two weeks after receiving the second dose, in accordance with the clinical trial data (Polack et al., 2020) . Concurrently to the beginning of the vaccination efforts, a meaningful morbidity peak was apparent ( Fig. 1) This was followed by an increase in reported active cases 2-3 weeks later (Fig. 1) . Another analysis, zooming on the appearance of the third morbidity peak, was done for observing new SARS-CoV-2 verified cases alongside our wastewater N gene RNA detection (Fig. S2 ). Wastewater N gene detection was not visible at a rate of lower than two new cases per day in the city and remained undetected in five measurements between June 1-17. On June 22, the first positive wastewater result was obtained, while notedly, a meaningful increase in cases was seen only a week later. This reappearance of increased morbidity continues throughout September 2021, despite vaccination percentages (second dose) of nearly 70% of the city's population. Previously, we reported the emergence of the Alpha variant of concern (B.1.1.7) in Israel by the end of January 2021 using RT-qPCR assay we developed (Yaniv et al., 2021) . Soon after appearance, the alpha variant dominated the original variant to such an extent that within one month all SARS-CoV-2 RNA traces in wastewater corresponded solely to the Alpha variant.

Moreover, the observed decline in morbidity, suggest the effectiveness of the Pfizer-BioNTech COVID-19 vaccine against the Alpha variant (Meng et al., 2021) . The reappearance of COVID-19 morbidity in June 2021 raised questions regarding the efficiency of the Pfizer-BioNTech COVID-19 vaccine. Is the vaccine less efficient over-time or it is compromised due to lack of compatibility to other variants of concerns?

Previously we developed direct RT-qPCR detection assays for the Alpha variant (B.1.17, British) and Beta variant (B.1.315, South Africa) (Yaniv et al., 2021) . The possibility that the new outbreak is a result of the invasion of a novel variant of concern that differs from the Alpha or Beta was suggested.

The most prominent variants of concern to invade Israel were the Gamma variant (P.1, Brazilian) or the Delta variant (B.1.617, Indian), therefore they were the most urgent variants in need for rapid detection.

We therefore developed direct RT-qPCR detection assays for these two variants of concern. Our design for detection of these two variants is based on the differences in gene sequence from the original SARS-CoV-2 sequence (NC_045512.2). The Gamma variant contains an insertion in the ORF8 region, and the Delta variant S gene contains a deletion known as Δ157-158. Accordingly, our primers-probe sets were designed with a focus on these regions (Figure 2a -sequences available in Table S1 ).

13 Figure 2 . RT-q-PCR primers-probe sets designed for the detection of SARS-CoV-2 Gamma and Delta variants. a, Detection primer sets designed for differentiation and identification of SARS-CoV-2 Gamma variant (P.1) and

Delta variant (B.1.617). Design was based on sequence changes between the original SARS-CoV-2 virus and variants of concern, with insertion after ORF8 for Gamma variant and deletion in the S gene of the Delta variant b, Calibration curves for primers-probe sets developed for variants of concern detection. Resulted Ct value plotted against the tested Log copy number. Error bars present standard deviation for ten replicates. c, Lower detection limit of P.1 and S∆157 primers-probe sets in wastewater matrix. RNA extracted from negative detection wastewater sample (No virus) spiked with known concentrations of positive template corresponding to each probe accordingly (10 0 -10 2 S gene template copies per μL) and Non-Template Control (NTC, water). ND -not detected. For Gamma variant detection, the designed forward primer is located at the end of ORF8 gene and the reverse primer is located at the beginning of the N gene, meaning that 28227-28286 bp of the original sequence are included. Within this range, the original SARS-CoV-2 and Gamma variant sequences are identical, apart from a four-nucleotide insertion in the Gamma lineage (Fig. 2a) . Using a detection set comprised of two primers meant to amplify the target region, a single probe (P.1 probe) was designed for the detection of the Gamma variant only (corresponding to the insertion). For the detection of the Delta variant, the designated detection region was chosen from within the S gene.

Focusing on S gene's 21989-22083 bp of the original sequence, the original SARS-CoV-2 sequence is identical to the Delta variant sequence with the exception of a 6 nucleotides deletion in the Delta lineage ( Fig. 2a) . Using a detection set comprised of two primers meant to amplify the target region, a single probe (S∆157 probe) was designed for the area corresponding to the deletions, resulting in the detection of the Delta variant only.

To ensure functionality, the described sets of primers and probes underwent characterization.

Initially, a calibration curve was generated for the two primers-probe sets, using dsDNA as a template.

A detection range of between 10 6 copies and 10 0 copies per µL was tested for each set (Fig. 2b) . Linear regression performed for the two probes demonstrated strong correlation. A limit of detection (LOD) could be determined for each primers-probe set and was identified as 10 0 copies per µL for the two sets ( Fig. 2b, Table S2 ). A LOD of 10 0 copies per µL, is equivalent to a LOD calculated as 2000 copies per L wastewater in wastewater samples that were extracted directly (defined as Raw in equation S1).

Additionally in wastewater samples that were concentrated and then extracted for RNA (defined as Concentrated in equation S2), 10 0 copies per µL LOD is equivalent to a calculated LOD of 500 copies per L wastewater. This indicates highly sensitive detection. Specificity of the described sets was examined with either dsDNA fragments from the original SARS-CoV-2, relevant to the assigned detection regions, or using wastewater found positive for the original SARS-CoV-2 and for the Alpha variant. Both sets did not manifest a signal when tested with such negative controls and were therefore found to be highly specific.

Wastewater matrix consists of various PCR inhibitors that are likely to affect the RT-qPCR performance, therefore there was a need to assess the primers-probe detection abilities in such a complex environment. Hence, primer-probe sets were further characterized within a more intricate matrix.

Wastewater from a rural area in Binyamina, Israel served as a more complex environment for the RT-qPCR assay. Wastewater samples were pre-determined as negative for SARS-CoV-2 using N gene detection. After confirming that the wastewater samples were negative, relevant dsDNA template copies were added exogenously at known concentrations (Fig. 2c) . These samples were then used for SARS-CoV-2 detection by the examined primers-probe sets. As can be seen in Figure 2c , despite the wastewater matrix, P.1 and S∆157 probes maintained high functionality with a LOD of 10 0 copies per µL, proving their sensitivity and stability.

After fully characterizing the developed primers-probe sets, revealing their specificity, sensitivity and durability, we employed them on recently collected wastewater samples. Until recently, the Alpha variant was the most dominant in Israel, however a noticeable decrease in this variant was observed in the past months. In May-June 2021, clinical reports indicated that the Delta variant had reached Israel and was responsible for the majority of new morbidity cases. Taking this into account, samples from different locations in the city of Modi'in were collected on June 23 rd , 2021 and tested for general SARS-CoV-2 presence, using N gene detection, as well as for the presence of the Alpha and Delta variants, using relevant S gene detection (Fig. 2d) . As can be seen in Figure 2d , all of the tested samples were positive to SARS-CoV-2 through N gene detection. However, none of the samples resulted in a positive detection for the Alpha variant. This corresponded to the disappearance of this variant in clinical tests as reported by health officials. Furthermore, all samples, except for one, resulted in a positive signal for the Delta variant using the specific designed primers-probe set described above. These field results confirmed the new primers-probe sets' ability to detect the Delta variant in a quantitative sensitive manner, even within a complex environment. This technology thus, can provide an assessment for variant of concern's geographical spread in the population. A Gamma variant primer-probe set was also employed on numerous wastewater samples; however, none resulted in a positive signal as yet.

Considering the importance of wastewater monitoring, as well as the possibility of their use in clinical settings, these new tools may serve for enhancing SARS-CoV-2 variants of concern detection in a population.

With the new RT-qPCR tool for detection of variants of concern in hand, we set out to identify and quantify the various variants of concern in Beer-Sheva's wastewater during the past year. Figure 3 illustrates the dynamics of the different SARS-CoV-2 variants in Beer-Sheva's wastewater. Prior work by our group (Yaniv et al., 2021) revealed that until January 2021, the original SARS-CoV-2 was apparently the only version of SARS-CoV-2 in Israel and was detected by the S1 primers-probe set Concurrent to the latest emergence of SARS-CoV-2 at end of June 2021 (Fig. 1) , we employed our previously developed detection primer-probe sets for the Alpha and Beta variants of concern (Yaniv et al., 2021) , together with the newly developed detection sets for the Gamma and Delta variants of concern.

18 Figure 3. RT-qPCR SARS-CoV-2 variants of concern analysis in the city of Beer-Sheva's wastewater and vaccination percentages during mid-November 2020 until October 2021. Original variant detected using S1 set (Blue columns), Alpha variant detected using SΔ69 set (Orange columns) and Delta variant detected using SΔ157 set (Green columns). Second dose vaccination (Black dashed line) and third dose vaccination (Magenta dashed line) percentages were extracted from the Ministry of Health database.

The results from the RT-qPCR assays on wastewater samples indicated that the Delta variant had arrived in Beer-Sheva city (Fig. 3) by the end of June 2021. None of the other variants of concern manifested a signal during late-June, July, August, September and October 2021, apart from the Delta variant. It is important to note, that as in our previous study (Yaniv et al., 2021) , the RNA detection levels of the S gene in wastewater samples are generally lower than the N gene. Here as well, positive 19 samples for SARS-CoV-2 RNA demonstrated detection levels of the S gene lower than the detection levels of the N gene, despite the demonstrated sensitivity of used designed sets. This was suggested to be related to different gene transcription levels between the N gene and S gene in the SARS-CoV-2 (Emanuel et al., 2021; Kim et al., 2020) , however such a subject requires further research.

Since first being documented in India, the Delta variant is known to be less responsive to the Pfizer-BioNTech COVID-19 vaccine due to S gene mutations (Mlcochova et al., 2021) . Antibodies generated by the vaccine are apparently less compatible for neutralization of the Delta variant. In fact, the wastewater epidemiology results presented in this study clearly reflects this lower immunity despite high vaccination percentages. Additionally, finding the Delta virus strain in wastewater may also reflect that despite vaccination, vaccinated people may still be infected and carry the virus while being asymptomatic. Supporting this notion is the Health ministry report in which ~50% of the clinically infected people in the current morbidity peak are vaccinated. Furthermore, a decrease in immunity as reflected by an increase in morbidity observed until the end of September could be also a result of decrease in antibodies in vaccinated and recovering people over time. Despite this, our results provide strong evidence for the connection of the presence of the Delta variant in wastewater to the observed morbidity, and this can serve as a partial explanation regarding the latest morbidity trend in Beer-Sheva with relation to the level vaccination and immunity in its population.

Nevertheless, in an effort to regain population-immunity, the booster vaccination efforts (third dose) began in the first week of August 2021. Only two months later, when over 40% of the population was vaccinated with the third dose, a moderated decrease emerged in SARS-CoV-2 RNA detection levels in the city's wastewater and a sharp decrease in reported morbidity cases occurred (Figs. 1 and 3) .

More data is needed to determine the possible effects of the third vaccination dose on the current morbidity peak. Yet, these results emphasize the importance and reliability of this study to use 20 wastewater as an epidemiology tool for early warning and policy decision-making in regards to pandemic containment.

The study presented here, consolidate data gathered on a single model city throughout the past year. The targeted research, demonstrated how wastewater-based epidemiology can serve as a tool for morbidity surveillance within the population, given a specific geographical area. Wastewater monitoring was able to provide early alerts of 2-3 weeks before three observed morbidity peaks during this study's time period. Combining our SARS-CoV-2 wastewater results with vaccination data, raised questions regarding vaccine induced immunity. Out of three observed morbidity peaks, as vaccine percentages increased to above 50%, the second peak's infection was lowered. Despite this, the infection reemerged into the third peak a month later, regardless of almost 70% vaccine coverage. An explanation to these observed results could be found in the exposure of the population to a new variant. We aimed to prove that our RT-qPCR assessment of SARS-CoV-2 variants for the Gamma (P.1) and Delta (B.1.617) can be used as an expansion to the previously published Alpha (B.1.1.7) and Beta (B.1.351) variants (Yaniv et al., 2021) probe sets and novel sets may be needed as more variants appear.

RT-qPCR primers-probe sets were designed based on sequence differences from the original SARS-CoV-2 and other variants. The new sets for Gamma and Delta variants detection, were found specific as well as sensitive, with a LOD of 10 0 both in sterile conditions and in sewage matrix.

Employment of the sets on Israel's wastewater was positive for the Delta variant and negative for the Gamma variant, corresponding to health officials reports for infections during the third peak. Having 4 different primers-probe sets for detection of the variants of concern (2 of which are presented for the first time here), enabled the identification and quantification of the SARS-CoV-2 variants presence the city's wastewater.

Interestingly, each observed morbidity peak in this study, corresponded to a different SARS-CoV-2 variant indicating the usefulness of this tool. The original variant responsible for the first peak, the Alpha variant responsible for the second peak and the Delta variant responsible for the third peak.

This study also demonstrated that a vaccine percentage of over 50% successfully contained the Alpha variant, as expected based on published in-vitro studies. Nevertheless, a vaccination percentage of almost 70% was not enough to prevent the outbreak and continuous spread of the Delta variant in the population. In order to regain and maintain vaccine-induced immunity for longer period in the population, an additional dose of a vaccine was given. This study validates that the booster vaccine rate of over 40% successfully started to reduce the Delta variant detection. However, further monitoring is required to fully elucidate the booster effect within the population. Overall, the tools used in this study can provide valuable information not only regarding morbidity, but also regarding vaccine induced immunity in the population.

First confirmed detection of SARS-CoV-2 in untreated wastewater in Australia: A proof of concept for the wastewater surveillance of COVID-19 in the community

Naturally occurring SARS-CoV-2 gene deletions close to the spike S1/S2 cleavage site in the viral quasispecies of COVID19 patients

Detection of SARS-CoV-2 variants by genomic analysis of wastewater samples in Israel

Regressing SARS-CoV-2 sewage measurements onto COVID-19 burden in the population: A proof-of-concept for quantitative environmental surveillance

Diagnosing the novel SARS-CoV-2 by quantitative RT-PCR: variations and opportunities

Variability in RT-qPCR assay parameters indicates unreliable SARS-CoV-2 RNA quantification for wastewater surveillance

Centers for Disease Control and Prevention, n.d. CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel

Long-term monitoring of SARS-COV-2 RNA in wastewater in Brazil: A more responsive and economical approach

lineage B.1.1.7 in England. Science (80-. ). 372, eabg3055

Use of bacteriophage MS2 as an internal control in viral 24 reverse transcription-PCR assays

Transcriptomic profiling of SARS-CoV-2 infected human cell lines identifies HSP90 as target for COVID-19 therapy

Deepening of in silico evaluation of sars-cov-2 detection rt-qpcr assays in the context of new variants

SARS-CoV-2 variants, spike mutations and immune escape

SARS-CoV-2 variant B.1.617 is resistant to Bamlanivimab and evades antibodies induced by infection and vaccination

SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo

Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight

The Architecture of SARS-CoV-2 Transcriptome

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

First detection of SARS-CoV-2 in untreated wastewaters in Italy

Tracking SARS-CoV-2 in Sewage: Evidence of Changes in Virus Variant 26

Predominance during COVID-19 Pandemic

The COVID-19 Genomics UK

SARS-CoV-2 B.1.617.2 Delta variant replication, sensitivity to neutralising antibodies and vaccine breakthrough

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

First detection of SARS-CoV-2 RNA in wastewater in North America: A study in Louisiana

GISAID: Global initiative on sharing all influenza data -from vision to reality

Circulating 28

SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity

Post-lockdown detection of SARS-CoV-2 RNA in the wastewater of Montpellier, France. One Heal

RT-qPCR Assays for Rapid Detection of the N501Y, 69-70del, K417N, and E484K SARS-CoV-2 Mutations: A Screening Strategy to Identify Variants With Clinical Impact

Genotyping RT-PCR for Population-Level Variant Screening and Epidemiologic Surveillance

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Escape from neutralizing antibodies 30

SARS-CoV-2 spike protein variants

Detection of SARS-CoV-2 in raw and treated wastewater in Germany -Suitability for COVID-19 surveillance and potential transmission risks

SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma

Wastewater surveillance of SARS-CoV-2 across 40 U.S. states from February to

SARS-CoV-2 Titers in Wastewater Are Higher than Expected from Clinically Confirmed Cases

Direct RT-qPCR assay for SARS-CoV-2 variants of concern (Alpha, B.1.1.7 and Beta, B.1.351) detection and quantification in wastewater

Author Contributions

share equal contribution to this manuscript. K.Y. designed sequences, conceived, performed and analyzed experiments and authored this manuscript. E.O. designed sequences, conceived and analyzed experiments and authored this manuscript

conceived experiments, supervised, provided research facilities and edited the manuscript

We thank Electra Company, which holds WWTP of Beer-Sheva management, especially Nikolay Schipunov. We thank KANDO and the Israeli Ministry of Health for providing us with the sewage samples from Modi'in city. We gratefully acknowledge GISAID database for access to SARS-CoV-2 variants sequences. We gratefully acknowledge Esti Kramarsky-Winter assistance for comments and scientific editing of the manuscript.

We would like to acknowledge funding from Ben Gurion University, The Corona Challenge Covid-19 (https://in.bgu.ac.il/en/corona-challenge/Pages/default.aspx) and funding from the Israeli ministry of Health.